Current and Future Treatment Strategies for Acute Myeloid Leukemia

Gain insight on the latest investigative treatments for AML including targeted therapies for FLT3- and IDH1/2-positive AML and combination strategies.

Share

Program Content

Activities

FLT3 Therapy in AML
My Thoughts on the Future of FLT3 Therapy in AML
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2020

Expires: July 30, 2021

Activities

Future AML Therapy
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 14, 2020

Expires: August 13, 2021

Faculty

cover img faculity

Naval G. Daver, MD

Associate Professor
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.